| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
| 300 |
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | (300) |
-
| 300 |
-
| | | Operating Expenses | | Research Development | 1,444 | 1,455 | 1,647 | 4,849 | | Selling General and Administrative | 893 | 1,072 | 1,779 | 2,513 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 12 | 26 | 32 | 168 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,350) | (2,552) | (3,159) | (7,530) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3) | (43) | 2 | 18 | | Earnings Before Interest And Taxes | (2,353) | (2,596) | (3,157) | (7,512) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,353) | (2,596) | (3,157) | (7,512) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,353) | (2,596) | (3,157) | (7,512) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,353) | (2,596) | (3,157) | (7,512) | | Preferred Stock And Other Adjustments | (376) | (1,232) |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,729) | ($3,828) | ($3,157) | ($7,512) |
|
0.02% Nasdaq 0.00%
Income Statement
